CASP3 and lip and oral cavity carcinoma: The ROS inhibitor NAC recovered the MECO-caused caspase 3 and caspase 3/7 activations (Figure 6B,C), suggesting that MECO causes ROS-mediated caspase 3 activations of oral cancer cells.